PAK4 Protein, Human (His-SUMO)

PAK4 is an important serine/threonine kinase that affects cytoskeletal regulation, cell migration, growth, and survival through multiple pathways. Activation triggered by various effectors induces autophosphorylation, targeting proteins such as SSH1 and LIMK1 to regulate cofilin activity and stabilize actin filaments. PAK4 Protein, Human (His-SUMO) is the recombinant human-derived PAK4 protein, expressed by E. coli , with N-SUMO, N-6*His labeled tag. The total length of PAK4 Protein, Human (His-SUMO) is 426 a.a., with molecular weight of 63.9 kDa.

PAK4, a serine/threonine protein kinase, exerts its influence across diverse signaling pathways, impacting cytoskeleton regulation, cell migration, growth, proliferation, and cell survival. Activation triggered by various effectors, such as growth factor receptors or active CDC42 and RAC1, induces a conformational change and subsequent autophosphorylation on multiple serine and/or threonine residues. PAK4's phosphorylation targets include the protein phosphatase SSH1, leading to increased inhibitory phosphorylation of the actin binding/depolymerizing factor cofilin. This results in decreased cofilin activity, promoting the stabilization of actin filaments. Additionally, PAK4 phosphorylates LIMK1, another kinase that inhibits cofilin activity. By phosphorylating integrin beta5/ITGB5, PAK4 regulates cell motility, while its phosphorylation of ARHGEF2 activates the downstream target RHOA, contributing to the regulation of focal adhesion assembly and actin stress fibers. PAK4 plays a crucial role in cell survival by phosphorylating the BCL2 antagonist of cell death, BAD. Alternatively, it inhibits apoptosis by preventing the binding of caspase-8 to death domain receptors, acting in a kinase-independent manner. Furthermore, PAK4 influences cell-cycle progression by controlling the levels of the cell-cycle regulatory protein CDKN1A and by phosphorylating RAN.

Human

E. coli

N-SUMO;N-6*His

O96013 (M1-R426)

10298  [NCBI]

MFGKRKKRVEISAPSNFEHRVHTGFDQHEQKFTGLPRQWQSLIEESARRPKPLVDPACITSIQPGAPKTIVRGSKGAKDGALTLLLDEFENMSVTRSNSLRRDSPPPPARARQENGMPEKPPGPRSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR

63.9 kDa

Greater than 90% as determined by reducing SDS-PAGE.

<1 EU/μg, determined by LAL method.